Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 4
1994 8
1996 2
1998 1
1999 1
2001 2
2004 2
2006 3
2007 2
2010 1
2014 2
2016 1
2017 2
2019 1
2020 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Results by year
Filters applied: . Clear all
Page 1
[Atelectasis].
Sukoh N, Kawakami Y. Sukoh N, et al. Ryoikibetsu Shokogun Shirizu. 1994;(3):338-41. Ryoikibetsu Shokogun Shirizu. 1994. PMID: 8151986 Review. Japanese. No abstract available.
[Round atelectasis].
Sukoh N, Kawakami Y. Sukoh N, et al. Ryoikibetsu Shokogun Shirizu. 1994;(3):284-6. Ryoikibetsu Shokogun Shirizu. 1994. PMID: 8151970 Review. Japanese. No abstract available.
Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902).
Ito S, Asahina H, Honjo O, Tanaka H, Honda R, Oizumi S, Nakamura K, Takamura K, Hommura F, Kawai Y, Ito K, Sukoh N, Yokoo K, Morita R, Harada T, Takashina T, Goda T, Dosaka-Akita H, Isobe H; Hokkaido Lung Cancer Clinical Study Group Trial. Ito S, et al. Among authors: sukoh n. Lung Cancer. 2021 Jun;156:12-19. doi: 10.1016/j.lungcan.2021.04.011. Epub 2021 Apr 15. Lung Cancer. 2021. PMID: 33872943
First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002).
Yamamoto G, Asahina H, Honjo O, Sumi T, Nakamura A, Ito K, Kikuchi H, Hommura F, Honda R, Yokoo K, Fujita Y, Oizumi S, Morita R, Ikezawa Y, Tanaka H, Kimura N, Sasaki T, Sukoh N, Takashina T, Harada T, Dosaka-Akita H, Isobe H; Hokkaido Lung Cancer Clinical Study Group Trial. Yamamoto G, et al. Among authors: sukoh n. Sci Rep. 2021 Nov 30;11(1):23140. doi: 10.1038/s41598-021-02561-z. Sci Rep. 2021. PMID: 34848786 Free PMC article.
A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703).
Fukumoto SI, Oizumi S, Harada M, Sukoh N, Nakano K, Fuke S, Sakakibara-Konishi J, Takamura K, Ito K, Fujita Y, Nishigaki Y, Harada T, Akie K, Kinoshita I, Amano T, Isobe H, Dosaka-Akita H, Nishimura M; Hokkaido Lung Cancer Clinical Study Group. Fukumoto SI, et al. Among authors: sukoh n. Cancer Chemother Pharmacol. 2020 Jul;86(1):117-127. doi: 10.1007/s00280-020-04104-1. Epub 2020 Jun 20. Cancer Chemother Pharmacol. 2020. PMID: 32564128 Clinical Trial.
[Primary racemose hemangioma of bronchial artery].
Sukoh N, Yamamoto H, Muroya K, Harada T, Suzuki A, Inoue M, Watanabe N, Kuroda R, Kamiizumi H. Sukoh N, et al. Nihon Kokyuki Gakkai Zasshi. 1999 Jan;37(1):67-71. Nihon Kokyuki Gakkai Zasshi. 1999. PMID: 10087880 Review. Japanese.
35 results